The headline claims LifeVantage reports the following results from their clinical research: 200%+ average increase in GLP-1 levels Average weight loss of 11 pounds in 12 weeks, with some participants losing up to 25 pounds 100% of participants who lost weight maintained muscle mass Up to 6% total body fat percentage lost Up to 24% visceral fat reduction 86% decreased food, salt, and soda cravings 95% decreased sugar cravings 89% decreased fast food cravings These numbers look impressive at first glance
Many people tolerate tirzepatide just fine with manageable side effects
Chou IW, Cheng YH, Chen YR, Hsieh PCH, King K
Evaluate for underlying GH deficiency using validated stimulation testing per Endocrine Society criteria before considering any GH-axis intervention [7]
Ultimately, the researchers believe this kind of rapid, AI-assisted social media analysis could become a useful way to spot early warning signs around emerging drugs and wellness trends